Search Tag: AI breast screening
2025 02 Sep
Population-based breast cancer screening programmes have been effective in reducing mortality across Europe, largely through the detection of smaller, node-negative tumours at earlier stages. However, conventional mammography faces challenges such as limited sensitivity, a shortage of radiologists and variation in diagnostic accuracy. Artificial...Read more
2025 02 Sep
Population-based breast cancer screening programmes have been effective in reducing mortality across Europe, largely through the detection of smaller, node-negative tumours at earlier stages. However, conventional mammography faces challenges such as limited sensitivity, a shortage of radiologists and variation in diagnostic accuracy. Artificial...Read more
2025 02 Sep
Population-based breast cancer screening programmes have been effective in reducing mortality across Europe, largely through the detection of smaller, node-negative tumours at earlier stages. However, conventional mammography faces challenges such as limited sensitivity, a shortage of radiologists and variation in diagnostic accuracy. Artificial...Read more
2025 20 Jun
Artificial Intelligence (AI) has shown promise in improving the efficiency and accuracy of breast cancer screening. While existing studies highlight population-level benefits, evidence regarding its performance across specific patient subgroups remains limited. The ARIES study—a large-scale, multicentre retrospective analysis of over 306,000 screening...Read more
2025 20 Jun
Artificial Intelligence (AI) has shown promise in improving the efficiency and accuracy of breast cancer screening. While existing studies highlight population-level benefits, evidence regarding its performance across specific patient subgroups remains limited. The ARIES study—a large-scale, multicentre retrospective analysis of over 306,000 screening...Read more
2025 20 Jun
Artificial Intelligence (AI) has shown promise in improving the efficiency and accuracy of breast cancer screening. While existing studies highlight population-level benefits, evidence regarding its performance across specific patient subgroups remains limited. The ARIES study—a large-scale, multicentre retrospective analysis of over 306,000 screening...Read more